» Articles » PMID: 39965008

Transcriptomic Analysis of Human Primary T Cells After Short-term Leucine-deprivation and Evaluation of Kinase GCN2's Role in Regulating Differential Gene Expression

Overview
Journal PLoS One
Date 2025 Feb 18
PMID 39965008
Authors
Affiliations
Soon will be listed here.
Abstract

Chimeric Antigen Receptor T (CAR-T) cells offer a promising strategy for cancer treatment. These CAR-T cells are either autologous or allogeneic T cells that are genetically modified to express a chimeric antigen receptor targeting a specific tumor antigen. Ongoing research aims to optimize the CAR-T cell efficacy, including strategies to modulate their metabolism. One such approach involves inducing transgene expression by activating the GCN2 kinase signaling pathway through dietary deprivation of an essential amino acid. In this study, we investigated the general impact of a 6-hour leucine deprivation on primary activated human T cells using RNA-seq technology. Our analysis identified 3,431 differentially expressed genes between T cells cultured in regular medium and those cultured in leucine-deprived medium. Gene Set Enrichment Analysis revealed that "TNFα signaling via NFκB", "interferon-γ response", and "unfolded protein response" gene sets were positively enriched, while "mTORC1 signaling", "Myc targets", and "oxidative phosphorylation" gene sets were negatively enriched. To further evaluate the involvement of GCN2 kinase in regulating the differential gene expression during the 6-hour leucine deprivation, T cells were cultured with or without a GCN2 inhibitor. We found that 59% of the differentially expressed genes in our dataset were dependent on the kinase GCN2 (n = 2028), with 1,140 up-regulated and 888 down-regulated genes. These findings suggest a promising strategy to enhance CAR-T cell efficacy by combining short amino acid starvation with transient overexpression of a target gene.

References
1.
Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

2.
Gauthier-Coles G, Rahimi F, Broer A, Broer S . Inhibition of GCN2 Reveals Synergy with Cell-Cycle Regulation and Proteostasis. Metabolites. 2023; 13(10). PMC: 10609202. DOI: 10.3390/metabo13101064. View

3.
Bhattacharya S, HuangFu W, Dong G, Qian J, Baker D, Karar J . Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses. Oncogene. 2012; 32(36):4214-21. PMC: 3766494. DOI: 10.1038/onc.2012.439. View

4.
Xu D, Dai W, Kutzler L, Lacko H, Jefferson L, Dennis M . ATF4-Mediated Upregulation of REDD1 and Sestrin2 Suppresses mTORC1 Activity during Prolonged Leucine Deprivation. J Nutr. 2019; 150(5):1022-1030. PMC: 7198311. DOI: 10.1093/jn/nxz309. View

5.
St Paul M, Saibil S, Kates M, Han S, Lien S, Laister R . Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapy. Cell Rep Med. 2024; 5(3):101465. PMC: 10983112. DOI: 10.1016/j.xcrm.2024.101465. View